Loading clinical trials...

RECRUITINGNA

Wellness, Intervention Strategies and HIV Care

NCT07069374•University of California, San Francisco

Summary

This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Participants must:
•Be at least 18 years of age
•Self-report biological characteristics consistent with the population under study
•Be HIV-positive
•Report use of at least one of the following substances in the last 90 days:
•* Cannabis
•* Methamphetamine
•* Cocaine/crack
•* Cocaine
•* Heroin
+9 more criteria

Exclusion Criteria

•Evidence of severe cognitive impairment or active psychosis that may impede ability to provide fully informed consent, determined by the research assistants and clinical supervisor(s)
•The research staff are trained on guidelines for identifying participants who exhibit signs of inability to meaningfully participate or provide consent due to mental illness or impairment

Locations (2)

Oakland MWCCS Site Office

Oakland, California, United States

SF MWCCS Site Office

San Francisco, California, United States

Key Dates

Start Date

September 1, 2025

Primary Completion Date

March 30, 2026

Completion Date

March 30, 2026

Last Updated

January 27, 2026

Enrollment

ESTIMATED participants

Conditions

HIVSubstance Use Disorder (SUD)

Interventions

Wellness, Intervention Strategies and HIV Care (WISH)

BEHAVIORAL

Movie Night Club - Attention and Time Matched Control

BEHAVIORAL

Contacts

Heather Freasier Project Director, MS

CONTACT

415-502-8800 heather.freasier@ucsf.edu

Julian Paredes-Gotamco Clinical Research Coordinator

CONTACT

415-502-3507 Julian.Paredes-Gotamco@ucsf.edu

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

View study

RECRUITING

Thinking and Memory Problems in People With HIV

NCT01875588

HIV Positive

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Wellness, Intervention Strategies and HIV Care

Inclusion Criteria

Exclusion Criteria

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Thinking and Memory Problems in People With HIV

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption